X
CLX icon

Xponance’s Clorox CLX Stock Holding History

Xponance’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
20,338
+235
+1% +$22.6K 0.01% 607
2026
Q1 		$2.08M Sell
20,103
-1,149
-5% -$130K 0.01% 562
2025
Q4 		$2.14M Buy
21,252
+1,293
+6% +$140K 0.02% 524
2025
Q3 		$2.46M Sell
19,959
-3,584
-15% -$445K 0.02% 498
2025
Q2 		$2.83M Sell
23,543
-4,876
-17% -$651K 0.02% 460
2025
Q1 		$4.18M Buy
28,419
+530
+2% +$80.9K 0.04% 342
2024
Q4 		$4.53M Sell
27,889
-317
-1% -$51.9K 0.04% 331
2024
Q3 		$4.6M Sell
28,206
-245
-0.9% -$36.3K 0.04% 326
2024
Q2 		$3.88M Buy
28,451
+181
+0.6% +$25.1K 0.04% 344
2024
Q1 		$4.33M Buy
28,270
+109
+0.4% +$16.3K 0.05% 330
2023
Q4 		$4.02M Sell
28,161
-1,182
-4% -$158K 0.05% 313
2023
Q3 		$3.85M Buy
29,343
+726
+3% +$110K 0.05% 302
2023
Q2 		$4.55M Buy
28,617
+2,631
+10% +$424K 0.06% 267
2023
Q1 		$4.11M Sell
25,986
-11,876
-31% -$1.78M 0.06% 278
2022
Q4 		$5.31M Buy
37,862
+14,666
+63% +$2.08M 0.09% 227
2022
Q3 		$2.98M Buy
23,196
+2,046
+10% +$295K 0.06% 299
2022
Q2 		$2.98M Buy
21,150
+2,850
+16% +$407K 0.06% 282
2022
Q1 		$2.54M Buy
18,300
+264
+1% +$40.5K 0.04% 318
2021
Q4 		$3.15M Buy
18,036
+1,568
+10% +$261K 0.05% 287
2021
Q3 		$2.73M Sell
16,468
-699
-4% -$120K 0.05% 282
2021
Q2 		$3.09M Buy
17,167
+2,564
+18% +$468K 0.06% 268
2021
Q1 		$2.82M Sell
14,603
-109
-0.7% -$21K 0.06% 258
2020
Q4 		$2.97M Buy
14,712
+245
+2% +$50.7K 0.06% 246
2020
Q3 		$3.04M Buy
14,467
+145
+1% +$32.3K 0.07% 210
2020
Q2 		$3.14M Buy
+14,322
New +$2.86M 0.08% 203

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Xponance's CLX Position: Q2 2026 in Review

Xponance increased its Clorox (CLX) stake by 1.2% in Q2 2026, buying an estimated $22.6K and bringing the position to 20,338 shares worth $1.94M. The position accounts for 0.01% of the portfolio, ranked #607.

Xponance first reported a position in CLX in Q2 2020 and has held it in 25 quarters since. The position peaked at $5.31M in Q4 2022. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Xponance held 20,338 shares of Clorox worth $1.94M as of Q2 2026.
  • Xponance bought 235 Clorox shares in Q2 2026, an estimated $22.6K.
  • Clorox made up 0.01% of Xponance's portfolio in Q2 2026, its #607 holding.
  • Xponance first reported a position in Clorox in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Clorox position peaked at $5.31M in Q4 2022.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.